| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,510 | $60 | $95.4K |
| 53854 | The provider uses a radiofrequency–generated water vapor thermal device to destroy prostate tissue to treat BPH and lower urinary tract symptoms. | 70 | $1,290 | $86.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 860 | $90 | $78.1K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 360 | $180 | $65.2K |
| 52442 | In this add–on procedure, the provider uses a cystourethroscope to place an additional permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 50 | $670 | $35.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 260 | $140 | $34.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 260 | $120 | $29.9K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 300 | $100 | $29.5K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 40 | $590 | $25.3K |
| 99442 | N/A | 330 | $60 | $18.8K |